Michael Baker
Net worth: 418 064 $ as of 31/05/2026
Net worth: 418 064 $ as of 31/05/2026
Michael Baker is currently Director at Radiopharm Theranostics (USA), Inc. and Investment Associate at Bioscience Managers Pty Ltd. Former roles include Chief Executive Officer, MD & Director at Arovella Therapeutics Ltd. from 2021 to 2026, Independent Non-Executive Director at Radiopharm Theranostics Ltd. from 2021 to 2024, and Senior Manager at Hexima Ltd. Education includes an MBA from Melbourne Business School and undergraduate and graduate degrees from La Trobe University, conferred in 2004 and 2009 respectively.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 04/05/2026 | 81,84,493 ( 0.68% ) | 418 064 $ | 31/05/2026 |
| Companies | Position | Start |
|---|---|---|
Bioscience Managers Pty Ltd.
Bioscience Managers Pty Ltd. Investment ManagersFinance Bioscience Managers invests in both public and private companies located in Asia, Australia and New Zealand. The firm focuses on healthcare and life sciences sectors. It participates in early and growth stage capital transactions. | Private Equity Analyst | 01/11/2017 |
Radiopharm Theranostics (USA), Inc.
Radiopharm Theranostics (USA), Inc. Pharmaceuticals: MajorHealth Technology Develops radiopharmaceutical products for diagnostic and therapeutic uses | Director/Board Member | - |
| Companies | Position | End |
|---|---|---|
| AROVELLA THERAPEUTICS LIMITED | Chief Executive Officer | 04/05/2026 |
| RADIOPHARM THERANOSTICS LIMITED | Director/Board Member | 26/03/2024 |
| HEXIMA LIMITED | Corporate Officer/Principal | - |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 7 |
|---|---|
Melbourne Business School
Melbourne Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Hexima Ltd.
Hexima Ltd. BiotechnologyHealth Technology Engages in research and development of plant-derived proteins for treatment of fungal nail infections and provides commercial property services | Health Technology |
Arovella Therapeutics Ltd.
Arovella Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals and distributes medical devices and consumables | Health Technology |
LaTrobe University
LaTrobe University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Bioscience Managers Pty Ltd.
Bioscience Managers Pty Ltd. Investment ManagersFinance Bioscience Managers invests in both public and private companies located in Asia, Australia and New Zealand. The firm focuses on healthcare and life sciences sectors. It participates in early and growth stage capital transactions. | Finance |
Radiopharm Theranostics Ltd.
Radiopharm Theranostics Ltd. Medical/Nursing ServicesHealth Services Provides nuclear diagnostic services | Health Services |
Radiopharm Theranostics (USA), Inc.
Radiopharm Theranostics (USA), Inc. Pharmaceuticals: MajorHealth Technology Develops radiopharmaceutical products for diagnostic and therapeutic uses | Health Technology |
Select your edition
All financial news and data tailored to specific country editions